On The Pen GLP-1 News
By Dave Knapp GLP-1 Industry Insider
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Dave Knapp GLP-1 Industry Insider
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 9
Reviews: 0
Episodes: 172
Description
On The Pen is the leading GLP-1 news podcast and platform covering obesity medicine, FDA actions, drug shortages, access policy, and the business of NuSH therapies. The podcast is in the top 1% of all podcasts globally, and On The Pen is a top Substack best-seller.
| Episode | Date |
|---|---|
|
Eli Lilly Earnings Call Q4 2025 Recap
|
Feb 04, 2026 |
|
Once Monthly GLP-1 Injection? Pfizer Drops New Data
|
Feb 03, 2026 |
|
A PCOS and Tirzepatide Trial. Finally
|
Jan 27, 2026 |
|
Over The Counter GLP-1 Prediction
|
Jan 20, 2026 |
|
GLP-1 PLUS Gastric Balloon for added Weight Loss!
|
Jan 19, 2026 |
|
GLP-1 Access, MariTide Data, and the Oprah Effect on Obesity Care
|
Jan 13, 2026 |
|
Wegovy Pens Recalled & Wegovy Pill Launch
|
Jan 06, 2026 |
|
Wegovy Pill Approved: First Ever GLP-1 Pill, As Good as Injections!
|
Dec 23, 2025 |
|
GLP-1 Compound Legislation: States are the Next Battlefield w/ Sabina Hemme
|
Dec 19, 2025 |
|
Compounded Retatrutide? What the Judge Said
|
Dec 16, 2025 |
|
Retatrutide Weight Loss: How Much At Each Dose
|
Dec 13, 2025 |
|
Mounjaro vs. New Obesity Drugs: Why Wave-007 Is Stealing the Spotlight
|
Dec 09, 2025 |
|
GLP-1: New Metrics, New Molecules, New Prices
|
Dec 02, 2025 |
|
Novo Nordisk Amycretin Shocker + Semaglutide Flopper
|
Nov 25, 2025 |
|
Wegovy GLP-1 Price Novo Blinks First
|
Nov 18, 2025 |
|
GLP-1 State of the Union
|
Nov 11, 2025 |
|
Lower Cost Zepbound and Wegovy? TrumpRX Announcement Incoming
|
Nov 04, 2025 |
|
Eli Lilly Earnings Call Recap: NEW GLP-1 GIP Peptide Announced!
|
Oct 30, 2025 |
|
Retatrutide + Tirzepatide Grey Market Clampdown + 1 Billion GLP-1 Pills Incoming
|
Oct 28, 2025 |
|
HLTH 2025: Obesity Care Superstar Interviews
|
Oct 22, 2025 |
|
TRUMP: Ozempic Will Soon be $150 in the US! Meet the Reporter Who Made Him Say It!
|
Oct 17, 2025 |
|
Wegovy and Ozempic Users: FDA's Scathing Report on Major Novo Factory
|
Oct 14, 2025 |
|
Retatrutide News That Could Change Everything for GLP-1 Compounds
|
Oct 07, 2025 |
|
Sobriety Meets Weight Loss: The Ethan Suplee Interview
|
Oct 07, 2025 |
|
Mounjaro Hair Loss + NFL Lineman Discovers Power in Personalized Medicine
|
Oct 03, 2025 |
|
Stopping Zepbound and Maintaining with Revita
|
Sep 30, 2025 |
|
GLP-1 Treatment and Advocacy with Dr. Leslie Golden
|
Sep 26, 2025 |
|
Pfizer GLP-1 Play Worth $7.3B + Compound Tirzepatide Update
|
Sep 23, 2025 |
|
GLP-1 Weight Loss, Why It's About So Much More for Patients
|
Sep 19, 2025 |
|
Compound GLP-1 Legislation + FDA Warning Letter to HIMS
|
Sep 16, 2025 |
|
FDA CRACKDOWN on Compounded GLP-1s | Novo’s Gut Hack & Lilly’s One-Shot Cure
|
Sep 09, 2025 |
|
Is Wegovy Better Than Zepbound? Plus the First Obesity GLP-1 Generic is Here!
|
Sep 02, 2025 |
|
Zepbound Compound Lawsuit Update: Eli Lilly Vs Mochi
|
Aug 30, 2025 |
|
Eli Lilly VS Mochi Update + Big Lilly Orforglipron Secret Revealed
|
Aug 26, 2025 |
|
Eli Lilly Orforglipron Secret Revealed! + Lill VS Mochi Update
|
Aug 26, 2025 |
|
Ozempic Price Cut + New Obesity Pill Data
|
Aug 19, 2025 |
|
GLP-1 Microdosing For Weight Loss: Noom CEO Explains Their New Program
|
Aug 13, 2025 |
|
Eli Lilly Earnings Call Recap: Stock Tanks on Weight Loss Pill Miss
|
Aug 07, 2025 |
|
Novo Nordisk Blames Compound Semaglutide on Slower Sales
|
Aug 07, 2025 |
|
No Compounded Retatrutide Says the FDA + Tons of GLP-1 News
|
Aug 05, 2025 |
|
LEAKED TRUMP DOCUMENT: Medicare to Cover Zepbound and Wegovy for Obesity
|
Aug 01, 2025 |
|
Retatrutide Drops are Crazy // OTP TWD 7.29.25
|
Jul 29, 2025 |
|
Compound GLP-1 Injections : You Won't Believe What The Obesity Society is Saying
|
Jul 22, 2025 |
|
Connecticut Making Ozempic!? Meet The Mastermind
|
Jul 18, 2025 |
|
SHOCKING: How GLP-1 Protects the Heart Beyond Weight Loss // OTP TWD 7.25.25
|
Jul 15, 2025 |
|
BREAKING: Insurance Approving Mounjaro Over Zepbound!? What is Going On!?
|
Jul 08, 2025 |
|
Behind the Scenes of the Obesity Drug Battle | Obesity Action Coalition President Interview
|
Jul 05, 2025 |
|
Unlocking Zepbound Insurance Coverage + More GLP-1 Good News // otp twd 7.1.25
|
Jul 01, 2025 |
|
Lilly Could Lose Their Tirzepatide Patent! Plus ADA Coverage // OTP TWD 06.24.25
|
Jun 24, 2025 |
|
Faces of The Fight: The Jamie Selzler Story
|
Jun 23, 2025 |
|
Zepbound Vials Drop, Amycretin Surges, FDA Fast Track, and a Dangerous Trend // TWD 6.17.25
|
Jun 17, 2025 |
|
GLP-1 Access Progress + The Race for Less Frequent Dosing: OTP TWD 6.10.25
|
Jun 10, 2025 |
|
Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens
|
Jun 03, 2025 |
|
Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?
|
May 20, 2025 |
|
Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything
|
May 13, 2025 |
|
Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25
|
May 06, 2025 |
|
CVS Drops Zepbound + Lilly Earnings Call Recap
|
May 01, 2025 |
|
Compound GLP-1 PubMed Data: What It Didn’t Tell Us
|
Apr 29, 2025 |
|
High Dose Semaglutide Incoming! How Much Will it Cost? // OTP TWD 4.22.25
|
Apr 22, 2025 |
|
Getting Insurance To Cover Skin Removal Surgery // OTP Eps 109
|
Apr 19, 2025 |
|
Counterfeit Ozempic at Pharmacies! // OTP TWD 4.15.25
|
Apr 15, 2025 |
|
GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108
|
Apr 11, 2025 |
|
Grow-Zempic!? These Students Discoverd a GLP-1 Plant!
|
Apr 11, 2025 |
|
Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad
|
Apr 09, 2025 |
|
GLP-1 Medicare Coverage: What is Going On // OTP TWD 04.08.2025
|
Apr 08, 2025 |
|
Are GLP-1 Meds For Life? Fractyl’s CEO Says “Not So Fast!”
|
Apr 06, 2025 |
|
Fake Sugar: 👍 or 👎 for Weight Loss With Dr. Spencer Nadolsky // OTP Eps 107
|
Apr 04, 2025 |
|
Tirzepatide Compounds: Lilly Sues Pharmacies // OTP TWD 04.01.25
|
Apr 01, 2025 |
|
Zepbound Weight Loss Stalls: Tips and Tricks // OTP Eps 106
|
Mar 29, 2025 |
|
Rare Exclusive Interview: OFA Chairman Sits Down with OTP to Talk Tirzepatide Lawsuit
|
Mar 26, 2025 |
|
Novo’s Retatrutide Competitor
|
Mar 25, 2025 |
|
Ozempic: Setting the Microdosing Strategy Straight w/ Dr Tyna Moore // OTP EPS 105
|
Mar 14, 2025 |
|
Compound Tirzepatide Latest // Cagrisema Disappoints Again // Great Vikingtide News
|
Mar 11, 2025 |
|
Obesity Bias in Medicine With Dr. Toomer // OTP Eps 104
|
Mar 07, 2025 |
|
Compound GLP-1 Accessibility + World Obesity Day // OTP TWD 03.04.25
|
Mar 04, 2025 |
|
Compound Tirzepatide Latest Updates // @Mike.OnAMssion2 Joins // OTP Eps 103
|
Feb 28, 2025 |
|
Lilly Drops Zepbound Price, Compounders Sue FDA (again) OTP TWD 2.25.25
|
Feb 25, 2025 |
|
Compound Tirzepatide Lawsuit Update / GLP-1 Heart Health w Dr Simin Lee / OTP Eps 102
|
Feb 21, 2025 |
|
503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25
|
Feb 18, 2025 |
|
Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101
|
Feb 14, 2025 |
|
Lilly Announces Next Gen Tirzepatide
|
Feb 11, 2025 |
|
GLP-1 Talk Show: An Emotional 100th On The Pen Live
|
Feb 07, 2025 |
|
Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap
|
Feb 06, 2025 |
|
Novo Nordisk Q4 '24 Earnings Call: Obesity Medicine Implications
|
Feb 05, 2025 |
|
Like Retatrutide But In A Pill? OTP TWD 2.4.25
|
Feb 04, 2025 |
|
463 Pound Zepbound Weight Loss // OTP Eps 99
|
Feb 02, 2025 |
|
503b Compounder Rocked by FDA Audit + OFA v FDA Trial Update
|
Jan 30, 2025 |
|
Kelly Matthew of GLP1 Real Talk Joins! OTP Eps 97
|
Jan 27, 2025 |
|
Massive Zepbound and Wegovy News // OTP TWD 1.21.25
|
Jan 21, 2025 |
|
TikTok GLP-1 Refugees Episode
|
Jan 17, 2025 |
|
Compounders Win Small Battle in War Over Zepbound and Mounjaro Shortages
|
Jan 15, 2025 |
|
Legal Expert: Compound Tirzepatide Trial Update || OTP Eps 96
|
Jan 10, 2025 |
|
Generic Liraglutide and GLP-1 Accessibility
|
Jan 08, 2025 |
|
More Generic GLP-1 Options Hit The Market!
|
Dec 30, 2024 |
|
On The Pen: The Weekly Dose 12.17.24
|
Dec 17, 2024 |
|
An Inflatable Stomach Balloon for Weight Loss
|
Dec 16, 2024 |
|
A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent
|
Dec 14, 2024 |
|
OFA Representation in Compound Tirzepatide Case Sits Down with OTP
|
Dec 11, 2024 |
|
CagriSema Delay? Novo Catalent Update
|
Dec 11, 2024 |
|
American Diabetes Association on the Wrong Side of Compounded GLP-1 Meds
|
Dec 03, 2024 |
|
Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan
|
Nov 29, 2024 |
|
Retatrutide Cagrisema & Obesity Medicine Future With Dr. Michael Albert
|
Nov 28, 2024 |
|
Medicare to Cover Zepbound and Wegovy?
|
Nov 26, 2024 |
|
Compound Tirzepatide Future + @FitFlavorFun : OTP EPS 91
|
Nov 23, 2024 |
|
On The Pen: The Weekly Dose 11.19.24
|
Nov 19, 2024 |
|
CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW
|
Nov 18, 2024 |
|
Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90
|
Nov 15, 2024 |
|
Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News
|
Nov 12, 2024 |
|
Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!
|
Nov 05, 2024 |
|
Lilly Earnings Call Analysis: Why Zepbound Missed Earnings
|
Oct 31, 2024 |
|
New Zepbound Savings Card, GLP-1 Accessibility Landscape Evolves
|
Oct 29, 2024 |
|
Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!
|
Oct 25, 2024 |
|
Tirzepatide Lawsuits Filed By Lilly, Catalent Reframing Novo Merger
|
Oct 22, 2024 |
|
Compounded Zepbound Legal Battle Landscape: Legal Expert Weighs In
|
Oct 18, 2024 |
|
Compounded Zepbound Uncertainty + Leveraging GLP-1 To Improve Labor Shortages
|
Oct 15, 2024 |
|
Heartbreaking Zepbound Story | OTP Eps 85
|
Oct 11, 2024 |
|
Tirzepatide Lawsuits + Ozempic Patent Victory
|
Oct 08, 2024 |
|
Megadosing Zepbound and Mounjaro With Dr. Daniel Rosen
|
Oct 04, 2024 |
|
Ozempic and Zepbound Supply Impacted by Port Worker Strike!
|
Oct 02, 2024 |
|
Amy Kane @AmyInHalf Discusses Dramatic Mounjaro Transformation
|
Sep 28, 2024 |
|
On The Pen: The Weekly Dose 9.24.24
|
Sep 24, 2024 |
|
Eli Lilly Compound Tirzepatide Letters + Retatrutide Trial Guest!
|
Sep 21, 2024 |
|
BCBS Demanding Refunds From Ozempic Prescribers? | The Weekly Dose 9.17.24
|
Sep 17, 2024 |
|
On The Pen: The Weekly Dose 9.10.24
|
Sep 10, 2024 |
|
Dr. Spencer Nadolsky On Compound Tirzepatide After Leaving Weight Watchers
|
Sep 06, 2024 |
|
Ozempic Shortages Extended | The Weekly Dose 9.3.24
|
Sep 03, 2024 |
|
Zepbound Savings Card & Zepbound Vials Discussion With The Downsized
|
Aug 30, 2024 |
|
Massive Zepbound Vials News 8.27.24
|
Aug 27, 2024 |
|
On The Pen: The Weekly Dose 8.20.24
|
Aug 19, 2024 |
|
On The Pen: The Weekly Dose 8.13.24
|
Aug 13, 2024 |
|
On The Pen: The Weekly Dose 8.6.24
|
Aug 06, 2024 |
|
On The Pen: The Weekly Dose 7.30.24
|
Jul 30, 2024 |
|
On The Pen: The Weekly Dose 7.23.24
|
Jul 22, 2024 |
|
On The Pen: The Weekly Dose 7.16.24
|
Jul 15, 2024 |
|
Amylin and the future of obesity medicine with Dr. Beverly Tchang
|
Jul 13, 2024 |
|
On The Pen: The Weekly Dose 7.9.24
|
Jul 08, 2024 |
|
On The Pen: The Weekly Dose 7.2.24
|
Jul 02, 2024 |
|
On The Pen: The Weekly Dose 6.25.24
|
Jun 25, 2024 |
|
On The Pen: The Weekly Dose 6.18.24
|
Jun 18, 2024 |
|
Zepbound And Liver Disease
|
Jun 12, 2024 |
|
On The Pen: The Weekly Dose 6.11.24
|
Jun 11, 2024 |
|
On The Pen: The Weekly Dose 6.4.24
|
Jun 04, 2024 |
|
OTP EPS 68: Ro CEO Zach Reitano Talks GLP-1 Supply Tracker
|
May 31, 2024 |
|
On The Pen: The Weekly Dose 5.28.24
|
May 28, 2024 |
|
On The Pen Live Eps 67: Survodutide Trial Participant Tells All!
|
May 25, 2024 |
|
On The Pen: The Weekly Dose 5.21.24
|
May 21, 2024 |
|
On The Pen: The Weekly Dose 5.14.24
|
May 14, 2024 |
|
Threats to Lilly's Zepbound & Mounjaro Printing Press
|
May 11, 2024 |
|
On The Pen: The Weekly Dose 5.7.24
|
May 08, 2024 |
|
Lilly Earnings Call: Zepbound and Mounjaro Updates
|
May 01, 2024 |
|
On The Pen: The Weekly Dose 4/30/24
|
Apr 30, 2024 |
|
On The Pen: The Weekly Dose 4/23/24
|
Apr 23, 2024 |
|
Zepbound Vials: The Business Case
|
Apr 19, 2024 |
|
On The Pen: The Weekly Dose 4/16/24
|
Apr 15, 2024 |
|
Sourcing Compound Tirzepatide
|
Apr 13, 2024 |
|
On The Pen: The Weekly Dose 4.9.24
|
Apr 09, 2024 |
|
Zepbound Single Dose Vials Approved!
|
Apr 01, 2024 |
|
On The Pen: The Weekly Dose 3/26/24
|
Mar 26, 2024 |
|
On The Pen: The Weekly Dose 3/19/24
|
Mar 19, 2024 |
|
Novo Nordisk Pipeline Obesity Medicines Announced
|
Mar 10, 2024 |
|
On The Pen: The Weekly Dose 3/5/24
|
Mar 05, 2024 |
|
Mounjaro to Zepbound and Beyond with Dr. Albert
|
Mar 01, 2024 |
|
On The Pen: The Weekly Dose 2/27/24
|
Feb 27, 2024 |
|
On The Pen: The Weekly Dose 2/20/24
|
Feb 20, 2024 |
|
Zepbound Mounjaro Ozempic News: 2.13.24
|
Feb 13, 2024 |
|
Q4 Eli Lilly Earnings Call Recap
|
Feb 07, 2024 |
|
On The Pen: The Weekly Dose 2.6.24
|
Feb 06, 2024 |
|
Q4 Novo Nordisk Earnings Call Recap
|
Feb 01, 2024 |
|
On The Pen: The Weekly Dose 1.30.24
|
Jan 30, 2024 |
|
On The Pen: The Weekly Dose 1.23.24
|
Jan 23, 2024 |
|
On The Pen: The Weekly Dose 1.16.24
|
Jan 16, 2024 |
|
On The Pen: The Weekly Dose Podcast!
|
Jan 14, 2024 |